Viewing StudyNCT00303667



Ignite Creation Date: 2024-05-05 @ 4:45 PM
Last Modification Date: 2024-10-26 @ 9:23 AM
Study NCT ID: NCT00303667
Status: COMPLETED
Last Update Posted: 2017-12-28
First Post: 2006-03-15

Brief Title: Donor Natural Killer Cells and Aldesleukin in Treating Patients wHigh Risk AML Undergoing Donor Stem Cell Transplant
Sponsor:
Organization: Masonic Cancer Center University of Minnesota